151 related articles for article (PubMed ID: 36224014)
1. Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL).
Du J; Qiu C; Li WS; Wang B; Han XL; Lin SW; Fu XH; Hou J; Huang ZF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):270. PubMed ID: 36224014
[TBL] [Abstract][Full Text] [Related]
2. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
Yang QX; Pei XJ; Tian XY; Li Y; Li Z
Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
[TBL] [Abstract][Full Text] [Related]
3. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL).
Pritchett JC; Yang ZZ; Kim HJ; Villasboas JC; Tang X; Jalali S; Cerhan JR; Feldman AL; Ansell SM
Leukemia; 2022 Jan; 36(1):165-176. PubMed ID: 34230608
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.
Krug A; Tosolini M; Madji Hounoum B; Fournié JJ; Geiger R; Pecoraro M; Emond P; Gaulard P; Lemonnier F; Ricci JE; Verhoeyen E
J Exp Clin Cancer Res; 2024 Feb; 43(1):43. PubMed ID: 38321568
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Lunning MA; Vose JM
Blood; 2017 Mar; 129(9):1095-1102. PubMed ID: 28115369
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Mourad N; Mounier N; Brière J; Raffoux E; Delmer A; Feller A; Meijer CJ; Emile JF; Bouabdallah R; Bosly A; Diebold J; Haioun C; Coiffier B; Gisselbrecht C; Gaulard P;
Blood; 2008 May; 111(9):4463-70. PubMed ID: 18292286
[TBL] [Abstract][Full Text] [Related]
7. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
8. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
[TBL] [Abstract][Full Text] [Related]
9. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
10. Advances in understanding of angioimmunoblastic T-cell lymphoma.
Chiba S; Sakata-Yanagimoto M
Leukemia; 2020 Oct; 34(10):2592-2606. PubMed ID: 32704161
[TBL] [Abstract][Full Text] [Related]
11. Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Beckers MM; Huls G
Eur J Haematol; 2013 Feb; 90(2):162-3. PubMed ID: 23227803
[TBL] [Abstract][Full Text] [Related]
12. Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.
Chen Z; Zhu Q; Deng X; Yao W; Zhang W; Liu W; Tang Y; Zhao S
Front Immunol; 2022; 13():987227. PubMed ID: 36325319
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma.
Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757
[TBL] [Abstract][Full Text] [Related]
15. [Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis].
Nanno S; Nakamae H; Kuwamura Y; Ishimura E; Sakabe M; Inaba A; Koh S; Yoshimura T; Nishimoto M; Hayashi Y; Terada Y; Nakane T; Koh H; Nakao Y; Ohsawa M; Hino M
Rinsho Ketsueki; 2013 Jul; 54(7):658-63. PubMed ID: 23912350
[TBL] [Abstract][Full Text] [Related]
16. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
[TBL] [Abstract][Full Text] [Related]
17. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
18. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
Delfau-Larue MH; de Leval L; Joly B; Plonquet A; Challine D; Parrens M; Delmer A; Salles G; Morschhauser F; Delarue R; Brice P; Bouabdallah R; Casasnovas O; Tilly H; Gaulard P; Haioun C
Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Schmitz N; Trümper L; Ziepert M; Nickelsen M; Ho AD; Metzner B; Peter N; Loeffler M; Rosenwald A; Pfreundschuh M
Blood; 2010 Nov; 116(18):3418-25. PubMed ID: 20660290
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
Cheng S; Zhang W; Inghirami G; Tam W
Elife; 2021 Sep; 10():. PubMed ID: 34581268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
